Vitamin D receptor: A highly versatile nuclear receptor

Kidney International

Volumn 72, Issue 3, 2007, Pages 237-239

  Wu Wong, J R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CELL NUCLEUS RECEPTOR; DOXERCALCIFEROL; PARICALCITOL; VITAMIN D RECEPTOR;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHRONIC KIDNEY DISEASE; HUMAN; HYPERPARATHYROIDISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 34547415473     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002428     Document Type: Note

References (15)

1. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780.
2. Tentori F, Hunt WC, Stidley CA et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865.
3. Teng M, Wolf M, Ofsthun MN et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125.
4. Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456.
5. Li YC, Qiao G, Uskokovic M et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90: 387-392.
6. Aihara K, Azuma H, Akaike M et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004; 279: 35798-35802.
7. Wu J, Garami M, Cheng T et al. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996; 97: 1577-1588.
8. Chen S, Nakamura K, Gardner DG. 1,25-Dihydroxyvitamin D inhibits human ANP gene promoter activity. Regul Pept 2005; 128: 197-202.
9. Chen S, Olsen K, Grigsby C, Gardner DG. Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells. Kidney Int 2007; 72: 300-306.
10. Knowles JW, Esposito G, Mao L et al. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 2001; 107: 975-984.
11. Wu-Wong JR, Nakane M, Ma J et al. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006; 186: 20-28.
12. Wu-Wong JR, Noonan W, Ma J et al. Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 2006; 318: 90-98.
13. Park CW, Oh YS, Shin YS et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 73-81.
14. Chen S, Costa CH, Nakamura K et al. Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly. J Biol Chem 1999; 274: 11260-11266.
15. Wu J, Garami M, Cao L et al. 1,25(OH)2D3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes. Am J Physiol 1995; 268: E1108-E1113.